US Stock MarketDetailed Quotes

RVMDW REVOLUTION MEDICINES INC C/WTS (TO PUR COM)

Watchlist
  • 0.080
  • 0.0000.00%
Close Sep 3 14:18 ET
0Market Cap0.00P/E (TTM)

About REVOLUTION MEDICINES INC C/WTS (TO PUR COM) Company

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Company Profile

SymbolRVMDW
Company NameREVOLUTION MEDICINES INC C/WTS (TO PUR COM)
Listing DateFeb 13, 2020
Founded2004
CEODr. Mark A. Goldsmith, M.D., PhD
MarketNASDAQ
Employees378
Fiscal Year Ends12-31
Address700 Saginaw Drive
CityRedwood City
ProvinceCalifornia
CountryUnited States of America
Zip Code94063
Phone1-650-481-6801
Websitehttp://www.revmed.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Mark A. Goldsmith, M.D., PhD
  • President, Chief Executive Officer and Chairman of the Board
  • 10.41M
  • Margaret A. Horn, J.D.
  • Chief Operating Officer
  • 4.39M
  • Jack Anders
  • Chief Financial Officer and Principal Accounting Officer
  • 3.05M
  • Dr. Wei Lin
  • Chief Medical Officer
  • --
  • Xiaolin Wang
  • Executive Vice President, Development
  • 3.23M
  • Jeff Cislini
  • Senior Vice President, General Counsel and Secretary
  • --
  • Ryan Asay
  • Senior Vice President, Corporate Affairs
  • --
  • Dr. Mason Shih, M.D.
  • Senior Vice President, Head of Drug Safety
  • --
  • Dr. Jing Yi, PhD
  • Senior Vice President, Head of Program Leadership.
  • --
  • Dr. Mary Pinder-Schenck, M.D.
  • Senior Vice President, Head of Medical Affairs
  • --
  • Dr. Stephen M. Kelsey, F.R.C.P.,M.D.
  • President, Research and Development
  • 4.39M
  • Dr. Sushil Patel, PhD
  • Independent Director
  • 475.19K
  • Elizabeth McKee Anderson, M.B.A.
  • Independent Director
  • 483.78K
  • Dr. Thilo Schroeder, PhD
  • Independent Director
  • --
  • Dr. Sandra J. Horning, M.D.
  • Independent Director
  • 720.00K
  • Alexis A. Borisy, A.M.
  • Lead Independent Director
  • 510.63K
  • Dr. Lorence H. Kim, M.D.
  • Independent Director
  • 489.99K
  • Dr. Flavia Borellini, PhD
  • Independent Director
  • 489.09K
  • Dr. Barbara L. Weber, M.D.
  • Independent Director
  • 480.19K
  • Frank K. Clyburn, Jr
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg